viatris glp-1 receptor agonist medications How Agonists Evolved from Diabetes to Weight Loss Treatments How GLP-1 medications are transforming
Description
The FDA and EMA have approved a number of GLP1 receptor agonists, but in this review, we will focus on those compounds that have been investigated preclinically, that is, exenatide, liraglutide, semaglutide and dulaglutide
GLP-1s act in the same fashion
Patients with pancreatic history should proceed cautiously
2nd & Duva, M
Research context Where semaglutide sits in the incretin field matters for comparative work
Pros: Long track record of safety
